AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Takeaway:
(SLB) faces a bearish technical outlook with an internal diagnostic score of 2.81, suggesting a weak trend and potential risk of decline, even as analysts remain optimistic.Schlumberger has received Strong Buy ratings from both Melius Research and
in the past 20 days, with an average rating score of 5.00 and a weighted rating score of 4.44. Analysts are broadly optimistic, though there is some divergence in historical performance: Melius Research has a perfect 100.00% historical win rate, while UBS has a 66.70% win rate.These ratings align with the recent 8.23% price increase, though the internal diagnostic score of 2.81 from technical analysis suggests caution. Key fundamentals include:
The mixed fundamental picture reflects moderate profitability and cash flow but a relatively high P/E and long operating cycle.
Despite the bearish technical outlook, fund flow data is positive, with an internal diagnostic score of 7.87. Large, extra-large, and medium-sized investors are all showing inflows—each with ratios above 48%. This suggests that while retail traders may be cautious, institutional money remains bullish, possibly driven by the broader energy sector optimism.
Schlumberger’s technical indicators are mostly bearish, with 3 out of 4 showing weakness:
Recent Chart Patterns:
Internal diagnostic insights: Bearish signals are clearly dominant (3 vs. 0 bullish), and the technical outlook is weak. Traders should consider the risk of a downward trend.
Schlumberger is caught in a tug-of-war between bearish technical signals and strong analyst optimism. While institutional money continues to flow in (score 7.87), technical indicators suggest caution with a score of 2.81. Investors might consider waiting for a pull-back or using the current price rise as an opportunity to take partial profits, especially as earnings or industry-specific catalysts could shift the momentum soon.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.

Dec.26 2025

Dec.26 2025

Dec.26 2025

Dec.26 2025

Dec.26 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet